Add To Watchlist
Share URL
About The Company
Description
Poltreg S.A.
Read More
Overview
Value
1
Growth
23
Health
60
Management
39
Analyst Opinion
69
Total
38
All Scores Out Of 100
Best Features
- Has a low level of debt
- Has strong financial health
- Low preportion of income is paid as dividend 0
Risk Factors
- Overvalued on cashflow basis
- Earnings have declined recently
- Income is not covering expenditure and investment
- Earnings are negative
- There is a history of diluting shareholders
- No margin of safety at their current market price
- Poor earnings and cashflow growth
- Accounting anomalies: Growing revenues without a corresponding growth in cash flows.
Market Peers
PTG.WA
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
-90.77%
Revenue Growth (5 Year Average)
11.70%
Ratings Consensus
Buy
Share Buybacks
-0.83%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
1
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 13.1 PLN ✘
Current Price: 54.6 PLN
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-3.99%
PE/Earnings Growth
N/A
Price/Book
2.51x
Growth
Growth Score
23
- ✔ 5 Year Average Revenue growth of 11.70% is higher than the market average (10.97%)
- ✔ Revenue growth has improved this yeara
- ✘ 5 Year Average Earnings growth of 13.44% is lower than the market average (14.48%)
- ✘ Earnings growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of -22.32% is lower than the market average (12.35%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
11.70%
Earnings Growth
13.44%
Cashflow Growth
-22.32%
Health
Health Score
60
Altman Z Score
N/A
Piostroski Score
N/A
Debt/Equity
0.00x
Current Assets/Liabilities
18.65x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
0.00x
Management
Management Score
39
Average Buybacks/Dilution
-0.83%
Recent Buybacks/Dilution
36.56%
5 Year Price Volitility
8.74%
Return On Assets
-4.66%
Return On Capital Employed
-2.22%
Return On Equity
-4.93%
Return On Free Cashflow
182.32%
Return On Investments
N/A
Analysts
Analyst Opinion
69
- ✔ Ratings consensus is Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Poltreg S.A.
Currency
PLN
Beta
0
Vol Avg
1502
Ceo
Mr. Piotr Trzonkowsk
Cik
Cusip
Exchange
Warsaw Stock Exchange
Full Time Employees
11
Industry
Biotechnology
Sector
Healthcare
Ipo Date
Address
Waly Piastowskie 1 lok. 1508
City
Gdansk
State
Country
PL
Zip
80-855
Phone
48 512 53 24 01
All financial data provided by FMP